152 related articles for article (PubMed ID: 37141482)
1. A Case of Progressive Cholestatic Drug-Induced Liver Injury Due to Terbinafine.
Ley D; Musto J; Said A
WMJ; 2023 May; 122(2):138-142. PubMed ID: 37141482
[TBL] [Abstract][Full Text] [Related]
2. The role of HLA-A*33:01 in patients with cholestatic hepatitis attributed to terbinafine.
Fontana RJ; Cirulli ET; Gu J; Kleiner D; Ostrov D; Phillips E; Schutte R; Barnhart H; Chalasani N; Watkins PB; Hoofnagle JH
J Hepatol; 2018 Dec; 69(6):1317-1325. PubMed ID: 30138689
[TBL] [Abstract][Full Text] [Related]
3. Terbinafine-induced prolonged cholestasis with reduction of interlobular bile ducts.
Mallat A; Zafrani ES; Metreau JM; Dhumeaux D
Dig Dis Sci; 1997 Jul; 42(7):1486-8. PubMed ID: 9246051
[TBL] [Abstract][Full Text] [Related]
4. Terbinafine-associated hepatic injury.
van 't Wout JW; Herrmann WA; de Vries RA; Stricker BH
J Hepatol; 1994 Jul; 21(1):115-7. PubMed ID: 7963410
[TBL] [Abstract][Full Text] [Related]
5. Terbinafine-induced hepatic failure requiring liver transplantation.
Perveze Z; Johnson MW; Rubin RA; Sellers M; Zayas C; Jones JL; Cross R; Thomas K; Butler B; Shrestha R
Liver Transpl; 2007 Jan; 13(1):162-4. PubMed ID: 17192859
[TBL] [Abstract][Full Text] [Related]
6. Concurrent terbinafine-induced acute generalised exanthematous pustulosis and hepatitis.
Carnio LR; Johnson Shaw ME; Schnur J; Casadesus D
BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33462036
[TBL] [Abstract][Full Text] [Related]
7. A curious case of cholestasis: oral terbinafine associated with cholestatic jaundice and subsequent erythema nodosum.
Kumar K; Gill A; Shafei R; Wright JL
BMJ Case Rep; 2014 Dec; 2014():. PubMed ID: 25480138
[TBL] [Abstract][Full Text] [Related]
8. [Hepatitis attributed to the use of terbinafine].
Boldewijn OY; Ottervanger JP; Mostart CM; Janssens AR; Calame J; Jonkers GJ
Ned Tijdschr Geneeskd; 1996 Mar; 140(12):669-72. PubMed ID: 8668241
[TBL] [Abstract][Full Text] [Related]
9. [Terbinafine-induced cholestatic liver injury].
Shiloah E; Horowiz M; Zecler E
Harefuah; 1997 Jul; 133(1-2):11-2, 80-1. PubMed ID: 9332048
[TBL] [Abstract][Full Text] [Related]
10. Terbinafine-induced liver injury.
Kaushal M; Tolani P; Kumar N; Sharma S
Natl Med J India; 2017; 30(6):321-323. PubMed ID: 30117442
[TBL] [Abstract][Full Text] [Related]
11. Terbinafine-induced hepatic dysfunction.
Chambers WM; Millar A; Jain S; Burroughs AK
Eur J Gastroenterol Hepatol; 2001 Sep; 13(9):1115-8. PubMed ID: 11564966
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis associated with terbinafine therapy: three case reports and a review of the literature.
Gupta AK; del Rosso JQ; Lynde CW; Brown GH; Shear NH
Clin Exp Dermatol; 1998 Mar; 23(2):64-7. PubMed ID: 9692307
[TBL] [Abstract][Full Text] [Related]
13. Terbinafine-induced acute autoimmune hepatitis in the setting of hepatitis B virus infection.
Paredes AH; Lewis JH
Ann Pharmacother; 2007 May; 41(5):880-4. PubMed ID: 17426078
[TBL] [Abstract][Full Text] [Related]
14. Terbinafine-induced hepatotoxicity.
Mejías Manzano MLÁ; Giráldez Gallego Á; Ontanilla Clavijo G; Sousa Martín JM
Gastroenterol Hepatol; 2019; 42(6):394-395. PubMed ID: 31167724
[No Abstract] [Full Text] [Related]
15. Terbinafine-associated hepatotoxicity.
Ajit C; Suvannasankha A; Zaeri N; Munoz SJ
Am J Med Sci; 2003 May; 325(5):292-5. PubMed ID: 12792250
[TBL] [Abstract][Full Text] [Related]
16. Terbinafine-induced cholestatic liver disease.
Lazaros GA; Papatheodoridis GV; Delladetsima JK; Tassopoulos NC
J Hepatol; 1996 Jun; 24(6):753-6. PubMed ID: 8835752
[TBL] [Abstract][Full Text] [Related]
17. Hydralazine-induced cholestatic hepatitis.
Hassan A; Hammad R; Cucco R; Niranjan S
Am J Ther; 2009; 16(4):371-3. PubMed ID: 19092641
[TBL] [Abstract][Full Text] [Related]
18. [Terbinafine and cholestatic hepatitis].
Tejada García M; Llvona Hevia AM; Martín Arias L; García-Pando AC
Med Clin (Barc); 1997 Sep; 109(9):356. PubMed ID: 9379769
[No Abstract] [Full Text] [Related]
19. Vanishing bile duct syndrome related to DILI and Hodgkin lymphoma overlap: A rare and severe case.
Greca RD; Cunha-Silva M; Costa LBE; Costa JGF; Mazo DFC; Sevá-Pereira T; Nascimento MMC; Pereira IE; Oliveira FC; Faria GAS; Neto FLP; Almeida JRS
Ann Hepatol; 2020; 19(1):107-112. PubMed ID: 31537508
[TBL] [Abstract][Full Text] [Related]
20. [Acute hepatitis associated with terbinafine].
Vivas S; Rodríguez M; Palacio MA; Cadenas F; Lomo J; Rodrigo L
Gastroenterol Hepatol; 1997 Nov; 20(9):456-8. PubMed ID: 9445740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]